Wyeth To File New Drugs In Japan

US pharmaceuticals and healthcare major Wyeth is to launch more drugs in Japan this year, with regulatory filings expected for six new products. Sales efforts on the company's locally leading product, the rheumatoid arthritis drug Embrel (etanercept) are also to be stepped

To read the full article, please choose one of the following options: